Treatment of congenital afibrinogenemia with cryoprecipitate collected through a plasmapheresis program using dedicated donors
A child with afibrinogenemia was evaluated for prophylactic cryoprecipitate transfusion due to recurrent episodes of traumatic bleeding. The parents would only consider ongoing transfusion therapy if a limited donor program could be established. Automated plasmapheresis was performed on a regular ba...
Gespeichert in:
| Veröffentlicht in: | Journal of clinical apheresis 1998, Vol.13 (4), p.143-145 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 145 |
|---|---|
| container_issue | 4 |
| container_start_page | 143 |
| container_title | Journal of clinical apheresis |
| container_volume | 13 |
| creator | Thompson, Hannis W. Touris, Sondra Giambartolomei, Sheryl Nuss, Rachelle |
| description | A child with afibrinogenemia was evaluated for prophylactic cryoprecipitate transfusion due to recurrent episodes of traumatic bleeding. The parents would only consider ongoing transfusion therapy if a limited donor program could be established. Automated plasmapheresis was performed on a regular basis on the patient's parents and a limited number of selected donors. Studies on the initial units collected demonstrated that a single 500 mL plasmapheresis yielded a mean of 606 mg fibrinogen in the cryoprecipitate, which was stored in two bags. A total of 166 U of cryoprecipitate from 84 individual plasmapheresis donations were transfused prophylactically every 2–3 weeks over a 16‐month period. Compared to transfusions from random donors, the use of a limited number of apheresis donors resulted in a donor exposure reduction of 87%. Clinically, the patient has had minimal bleeding during this period. J. Clin. Apheresis 13:143–145, 1998. © 1998 Wiley‐Liss, Inc. |
| doi_str_mv | 10.1002/(SICI)1098-1101(1998)13:4<143::AID-JCA1>3.0.CO;2-C |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69135487</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69135487</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4121-c26ca237c9e38b41062a79aef145b97b864435b757a99383db164d52abb2de933</originalsourceid><addsrcrecordid>eNp9kVtv00AQhS0EKqHwE5D8gFD74LA3XzZFSKmBkqo0EhSQeBmt1-NkwTd2HZW88NtZkyh9APG0Gs3ZM2fmC4IZJVNKCHtx8nGRL04pkVlEKaEnVMrslPKZeEkFn83mi9fRZT6nr_iUTPPlGYvye8HkIL8fTEjKecRELB8Gj5z7RgiRksdHwZHMsiSVbBL8urGohgbbIeyqUHftClszqDpUlSmsaTtfY2NUeGuGdajttustatN7zYBeX9eoByzDYW27zWodqrCvlWtUv0aLzriwt93KqibcONOuwhJLo9X4oezazrrHwYNK1Q6f7N_j4NPbNzf5u-hqebHI51eRFpTRSLNEK8ZTLZFnhaAkYSqVCisq4kKmRZYIweMijVPlF8x4WdBElDFTRcFKlJwfB893vj7Ojw26ARrjNNa1arHbOEgk5bHIUi_8sBNq2zlnsYLemkbZLVACIxSAEQqMV4bxyjBCAcpBgIcC4KHACAU4EMiXwCD3pk_30zdFg-XBck_B95_t-8ppVVdWtdq4u8kJF5wld9luTY3bv4L9N9c_Yv2pvWm0MzVuwJ8HU2W_Q5LyNIYv1xdAP2fX5-8vz-Er_w0FJ8SQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69135487</pqid></control><display><type>article</type><title>Treatment of congenital afibrinogenemia with cryoprecipitate collected through a plasmapheresis program using dedicated donors</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Thompson, Hannis W. ; Touris, Sondra ; Giambartolomei, Sheryl ; Nuss, Rachelle</creator><creatorcontrib>Thompson, Hannis W. ; Touris, Sondra ; Giambartolomei, Sheryl ; Nuss, Rachelle</creatorcontrib><description>A child with afibrinogenemia was evaluated for prophylactic cryoprecipitate transfusion due to recurrent episodes of traumatic bleeding. The parents would only consider ongoing transfusion therapy if a limited donor program could be established. Automated plasmapheresis was performed on a regular basis on the patient's parents and a limited number of selected donors. Studies on the initial units collected demonstrated that a single 500 mL plasmapheresis yielded a mean of 606 mg fibrinogen in the cryoprecipitate, which was stored in two bags. A total of 166 U of cryoprecipitate from 84 individual plasmapheresis donations were transfused prophylactically every 2–3 weeks over a 16‐month period. Compared to transfusions from random donors, the use of a limited number of apheresis donors resulted in a donor exposure reduction of 87%. Clinically, the patient has had minimal bleeding during this period. J. Clin. Apheresis 13:143–145, 1998. © 1998 Wiley‐Liss, Inc.</description><identifier>ISSN: 0733-2459</identifier><identifier>EISSN: 1098-1101</identifier><identifier>DOI: 10.1002/(SICI)1098-1101(1998)13:4<143::AID-JCA1>3.0.CO;2-C</identifier><identifier>PMID: 9886792</identifier><identifier>CODEN: JCAPES</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>afibrinogenemia ; Afibrinogenemia - congenital ; Afibrinogenemia - therapy ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Blood Donors ; Blood Preservation - methods ; Blood Specimen Collection - methods ; Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis ; Chemical Precipitation ; cryoprecipitate ; Cryopreservation ; Humans ; Infant ; limited donor exposure ; Male ; Medical sciences ; Plasmapheresis ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><ispartof>Journal of clinical apheresis, 1998, Vol.13 (4), p.143-145</ispartof><rights>Copyright © 1998 Wiley‐Liss, Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4121-c26ca237c9e38b41062a79aef145b97b864435b757a99383db164d52abb2de933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291098-1101%281998%2913%3A4%3C143%3A%3AAID-JCA1%3E3.0.CO%3B2-C$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291098-1101%281998%2913%3A4%3C143%3A%3AAID-JCA1%3E3.0.CO%3B2-C$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,4025,27925,27926,27927,45576,45577</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1634326$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9886792$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thompson, Hannis W.</creatorcontrib><creatorcontrib>Touris, Sondra</creatorcontrib><creatorcontrib>Giambartolomei, Sheryl</creatorcontrib><creatorcontrib>Nuss, Rachelle</creatorcontrib><title>Treatment of congenital afibrinogenemia with cryoprecipitate collected through a plasmapheresis program using dedicated donors</title><title>Journal of clinical apheresis</title><addtitle>J. Clin. Apheresis</addtitle><description>A child with afibrinogenemia was evaluated for prophylactic cryoprecipitate transfusion due to recurrent episodes of traumatic bleeding. The parents would only consider ongoing transfusion therapy if a limited donor program could be established. Automated plasmapheresis was performed on a regular basis on the patient's parents and a limited number of selected donors. Studies on the initial units collected demonstrated that a single 500 mL plasmapheresis yielded a mean of 606 mg fibrinogen in the cryoprecipitate, which was stored in two bags. A total of 166 U of cryoprecipitate from 84 individual plasmapheresis donations were transfused prophylactically every 2–3 weeks over a 16‐month period. Compared to transfusions from random donors, the use of a limited number of apheresis donors resulted in a donor exposure reduction of 87%. Clinically, the patient has had minimal bleeding during this period. J. Clin. Apheresis 13:143–145, 1998. © 1998 Wiley‐Liss, Inc.</description><subject>afibrinogenemia</subject><subject>Afibrinogenemia - congenital</subject><subject>Afibrinogenemia - therapy</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Blood Donors</subject><subject>Blood Preservation - methods</subject><subject>Blood Specimen Collection - methods</subject><subject>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</subject><subject>Chemical Precipitation</subject><subject>cryoprecipitate</subject><subject>Cryopreservation</subject><subject>Humans</subject><subject>Infant</subject><subject>limited donor exposure</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Plasmapheresis</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><issn>0733-2459</issn><issn>1098-1101</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kVtv00AQhS0EKqHwE5D8gFD74LA3XzZFSKmBkqo0EhSQeBmt1-NkwTd2HZW88NtZkyh9APG0Gs3ZM2fmC4IZJVNKCHtx8nGRL04pkVlEKaEnVMrslPKZeEkFn83mi9fRZT6nr_iUTPPlGYvye8HkIL8fTEjKecRELB8Gj5z7RgiRksdHwZHMsiSVbBL8urGohgbbIeyqUHftClszqDpUlSmsaTtfY2NUeGuGdajttustatN7zYBeX9eoByzDYW27zWodqrCvlWtUv0aLzriwt93KqibcONOuwhJLo9X4oezazrrHwYNK1Q6f7N_j4NPbNzf5u-hqebHI51eRFpTRSLNEK8ZTLZFnhaAkYSqVCisq4kKmRZYIweMijVPlF8x4WdBElDFTRcFKlJwfB893vj7Ojw26ARrjNNa1arHbOEgk5bHIUi_8sBNq2zlnsYLemkbZLVACIxSAEQqMV4bxyjBCAcpBgIcC4KHACAU4EMiXwCD3pk_30zdFg-XBck_B95_t-8ppVVdWtdq4u8kJF5wld9luTY3bv4L9N9c_Yv2pvWm0MzVuwJ8HU2W_Q5LyNIYv1xdAP2fX5-8vz-Er_w0FJ8SQ</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>Thompson, Hannis W.</creator><creator>Touris, Sondra</creator><creator>Giambartolomei, Sheryl</creator><creator>Nuss, Rachelle</creator><general>John Wiley & Sons, Inc</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1998</creationdate><title>Treatment of congenital afibrinogenemia with cryoprecipitate collected through a plasmapheresis program using dedicated donors</title><author>Thompson, Hannis W. ; Touris, Sondra ; Giambartolomei, Sheryl ; Nuss, Rachelle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4121-c26ca237c9e38b41062a79aef145b97b864435b757a99383db164d52abb2de933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>afibrinogenemia</topic><topic>Afibrinogenemia - congenital</topic><topic>Afibrinogenemia - therapy</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Blood Donors</topic><topic>Blood Preservation - methods</topic><topic>Blood Specimen Collection - methods</topic><topic>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</topic><topic>Chemical Precipitation</topic><topic>cryoprecipitate</topic><topic>Cryopreservation</topic><topic>Humans</topic><topic>Infant</topic><topic>limited donor exposure</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Plasmapheresis</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thompson, Hannis W.</creatorcontrib><creatorcontrib>Touris, Sondra</creatorcontrib><creatorcontrib>Giambartolomei, Sheryl</creatorcontrib><creatorcontrib>Nuss, Rachelle</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical apheresis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thompson, Hannis W.</au><au>Touris, Sondra</au><au>Giambartolomei, Sheryl</au><au>Nuss, Rachelle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of congenital afibrinogenemia with cryoprecipitate collected through a plasmapheresis program using dedicated donors</atitle><jtitle>Journal of clinical apheresis</jtitle><addtitle>J. Clin. Apheresis</addtitle><date>1998</date><risdate>1998</risdate><volume>13</volume><issue>4</issue><spage>143</spage><epage>145</epage><pages>143-145</pages><issn>0733-2459</issn><eissn>1098-1101</eissn><coden>JCAPES</coden><abstract>A child with afibrinogenemia was evaluated for prophylactic cryoprecipitate transfusion due to recurrent episodes of traumatic bleeding. The parents would only consider ongoing transfusion therapy if a limited donor program could be established. Automated plasmapheresis was performed on a regular basis on the patient's parents and a limited number of selected donors. Studies on the initial units collected demonstrated that a single 500 mL plasmapheresis yielded a mean of 606 mg fibrinogen in the cryoprecipitate, which was stored in two bags. A total of 166 U of cryoprecipitate from 84 individual plasmapheresis donations were transfused prophylactically every 2–3 weeks over a 16‐month period. Compared to transfusions from random donors, the use of a limited number of apheresis donors resulted in a donor exposure reduction of 87%. Clinically, the patient has had minimal bleeding during this period. J. Clin. Apheresis 13:143–145, 1998. © 1998 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>9886792</pmid><doi>10.1002/(SICI)1098-1101(1998)13:4<143::AID-JCA1>3.0.CO;2-C</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0733-2459 |
| ispartof | Journal of clinical apheresis, 1998, Vol.13 (4), p.143-145 |
| issn | 0733-2459 1098-1101 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69135487 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | afibrinogenemia Afibrinogenemia - congenital Afibrinogenemia - therapy Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Blood Donors Blood Preservation - methods Blood Specimen Collection - methods Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis Chemical Precipitation cryoprecipitate Cryopreservation Humans Infant limited donor exposure Male Medical sciences Plasmapheresis Transfusions. Complications. Transfusion reactions. Cell and gene therapy |
| title | Treatment of congenital afibrinogenemia with cryoprecipitate collected through a plasmapheresis program using dedicated donors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T12%3A52%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20congenital%20afibrinogenemia%20with%20cryoprecipitate%20collected%20through%20a%20plasmapheresis%20program%20using%20dedicated%20donors&rft.jtitle=Journal%20of%20clinical%20apheresis&rft.au=Thompson,%20Hannis%20W.&rft.date=1998&rft.volume=13&rft.issue=4&rft.spage=143&rft.epage=145&rft.pages=143-145&rft.issn=0733-2459&rft.eissn=1098-1101&rft.coden=JCAPES&rft_id=info:doi/10.1002/(SICI)1098-1101(1998)13:4%3C143::AID-JCA1%3E3.0.CO;2-C&rft_dat=%3Cproquest_cross%3E69135487%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69135487&rft_id=info:pmid/9886792&rfr_iscdi=true |